Wickert, R.; Tessonnier, T.; Deng, M.; Adeberg, S.; Seidensaal, K.; Hoeltgen, L.; Debus, J.; Herfarth, K.; Harrabi, S.B.
Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma. Cancers 2022, 14, 5865.
https://doi.org/10.3390/cancers14235865
AMA Style
Wickert R, Tessonnier T, Deng M, Adeberg S, Seidensaal K, Hoeltgen L, Debus J, Herfarth K, Harrabi SB.
Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma. Cancers. 2022; 14(23):5865.
https://doi.org/10.3390/cancers14235865
Chicago/Turabian Style
Wickert, Ricarda, Thomas Tessonnier, Maximilian Deng, Sebastian Adeberg, Katharina Seidensaal, Line Hoeltgen, Jürgen Debus, Klaus Herfarth, and Semi B. Harrabi.
2022. "Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma" Cancers 14, no. 23: 5865.
https://doi.org/10.3390/cancers14235865
APA Style
Wickert, R., Tessonnier, T., Deng, M., Adeberg, S., Seidensaal, K., Hoeltgen, L., Debus, J., Herfarth, K., & Harrabi, S. B.
(2022). Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma. Cancers, 14(23), 5865.
https://doi.org/10.3390/cancers14235865